Molina Healthcare (MOH) EBITDA Margin (2010 - 2026)
Molina Healthcare (MOH) posted EBITDA Margin of 1.33% for Q2 2026, up 46.9% sequentially from 0.91% in Q1 2026, and down 193.0% YoY from 1.43% in Q2 2025.
Molina Healthcare (MOH) EBITDA Margin (2010 - 2026) Analysis & Trends
Molina Healthcare has reported EBITDA Margin for 17 years, with the latest figure at 1.33% in Q2 2026.
- Quarterly EBITDA Margin fell 193.0% year-over-year to 1.33% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.49% (down 332.0% YoY) and the FY2025 annual result came in at 1.72%, down 248.0% from the prior year.
- EBITDA Margin grew to 1.33% in Q2 2026 per MOH's latest filing, from 0.91% in the prior quarter.
- Over five years, EBITDA Margin peaked at 5.58% in Q1 2023 and troughed at 1.42% in Q4 2025.
- A 5-year average of 3.44% and a median of 4.2% in 2023 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin surged 136 bps in 2022, then plunged 504 bps in 2025.
- Over 5 years, EBITDA Margin stood at 4.5% in 2022, then retreated by 22 bps to 3.49% in 2023, then advanced by 4 bps to 3.62% in 2024, then sank by 139 bps to 1.42% in 2025, then soared by 194 bps to 1.33% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 1.33%, 0.91%, and 1.42% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Unitedhealth | 346.93 Bn | 315.46 Bn | 36.67 Bn | 7.13% |
| 2 | Cvs Health | 119.91 Bn | 105.95 Bn | 47.23 Bn | 4.43% |
| 3 | Elevance Health | 86.25 Bn | 50.30 Bn | 13.45 Bn | 1.39% |
| 4 | Humana | 45.69 Bn | 21.82 Bn | 5.50 Bn | 3.77% |
| 5 | Centene | 31.66 Bn | 4.60 Bn | 14.55 Bn | 2.50% |
| 6 | Molina Healthcare | 10.12 Bn | 1.21 Bn | 1.43 Bn | 1.33% |
| 7 | Oscar Health | 9.48 Bn | 922.10 Mn | 1.09 Bn | 7.96% |
| 8 | Alignment Healthcare | 2.69 Bn | 1.99 Bn | 180.96 Mn | 3.74% |
| 9 | Clover Health Investments | 2.16 Bn | 1.92 Bn | 153.00 Mn | 3.77% |
| 10 | Progyny | 2.03 Bn | 1.79 Bn | 89.30 Mn | 11.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33% |
| Mar 31, 2026 | 0.91% |
| Dec 31, 2025 | -1.42% |
| Sep 30, 2025 | 1.19% |
| Jun 30, 2025 | 3.26% |
| Mar 31, 2025 | 3.88% |
| Dec 31, 2024 | 3.62% |
| Sep 30, 2024 | 4.52% |
| Jun 30, 2024 | 4.39% |
| Mar 31, 2024 | 4.29% |
| Dec 31, 2023 | 3.49% |
| Sep 30, 2023 | 4.20% |
| Jun 30, 2023 | 5.32% |
| Mar 31, 2023 | 5.58% |
| Sep 30, 2022 | 4.50% |
| Jun 30, 2022 | 4.63% |
| Mar 31, 2022 | 4.79% |
| Dec 31, 2021 | 2.58% |
| Sep 30, 2021 | 3.14% |
| Jun 30, 2021 | 4.01% |